A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma

Clinical trial NCT01864538 · TERMINATED

Trial details

NCT number: NCT01864538
Sponsor: ImmunoGenesis
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2013-05-01
Primary completion: 2015-09-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.